Tom Reed
Direktor/Vorstandsmitglied bei NeuroGenetic Pharmaceuticals, Inc.
Ursprung des Netzwerks ersten Grades von Tom Reed
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
NeuroGenetic Pharmaceuticals, Inc.
 NeuroGenetic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeuroGenetic Pharmaceuticals, Inc. discovers and develops drugs for the prevention of neurodegenerative conditions. The company was founded by William T. Comer, Rudy Tanzi and Steven L. Wagner in 2009 and is headquartered in Del Mar, CA.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Tom Reed
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| CONNECT BIOPHARMA HOLDINGS LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
Kiniksa Pharmaceuticals Corp.
 Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of Kiniksa Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The company is based in Lexington, MA. The CEO of the company is Sanj K. Patel. | Pharmaceuticals: Major | Director/Board Member | |
| KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC | Pharmaceuticals: Major | Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| HERON THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Pfizer (La Jolla)
 Pfizer (La Jolla) Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Pfizer (La Jolla) is a company that provides research services. The company is based in San Diego, CA. The company was founded by Michael R. Jirousek. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| The University of California, San Francisco | College/University | Doctorate Degree | |
Napo Pharmaceuticals, Inc.
 Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Napo Pharmaceuticals, Inc. provides pharmaceutical products for gastro-intestinal disorders. The company was founded by Lisa A. Conte in November 2001 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | President | |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Founder | |
| TRACON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
UC San Diego Foundation
 UC San Diego Foundation Investment Trusts/Mutual FundsMiscellaneous UC San Diego Foundation specializes in obtaining private gifts in support of research, teaching, and public service, as well as engages in management of gift assets. The company is was founded in 1972 and is headquartered in La Jolla, CA. | Investment Trusts/Mutual Funds | Director/Board Member | |
| La Jolla Institute for Molecular Medicine | Director/Board Member | ||
Tetragenex Pharmaceuticals, Inc.
 Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Pharmaceuticals: Major | Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Carleton College | College/University | Undergraduate Degree | |
| University of Iowa | College/University | Doctorate Degree | |
PNO Resources Ltd.
 PNO Resources Ltd. Other Metals/MineralsNon-Energy Minerals PNO Resources Ltd. engages in the acquisition and exploration of natural resource properties. The company was founded on February 22, 1983 and is headquartered in Vancouver, Canada. | Other Metals/Minerals | Chairman | |
| Medical College of Virginia | College/University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 27 |
| Kanada | 2 |
Sektoral
| Health Technology | 20 |
| Consumer Services | 5 |
| Commercial Services | 2 |
| Miscellaneous | 2 |
| Non-Energy Minerals | 2 |
Operativ
| Director/Board Member | 19 |
| President | 5 |
| Chairman | 4 |
| Chief Executive Officer | 4 |
| Doctorate Degree | 3 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| William T. Comer | 15 |
| Barry Quart | 14 |
| Maria Z. Kounnas | 2 |
